Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.995
-0.005 (-0.49%)
Nov 21, 2024, 12:23 PM EST - Market open
Lucid Diagnostics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 54 | 60 | 53 | 198 | - | - | |
Market Cap Growth | -10.14% | 12.22% | -73.09% | - | - | - | |
Enterprise Value | 107 | 63 | 26 | 197 | - | - | |
Last Close Price | 1.00 | 1.41 | 1.36 | 5.37 | - | - | |
PS Ratio | 11.10 | 24.58 | 141.08 | 395.32 | - | - | |
PB Ratio | 6.94 | -25.83 | 2.31 | 3.61 | - | - | |
P/TBV Ratio | - | - | 2.71 | 3.61 | - | - | |
EV/Sales Ratio | 25.61 | 25.79 | 68.61 | 394.82 | - | - | |
Debt / Equity Ratio | 2.06 | -6.60 | 0.09 | - | - | - | |
Asset Turnover | 0.15 | 0.08 | 0.01 | 0.02 | - | - | |
Inventory Turnover | 15.25 | 30.74 | 11.97 | 0.88 | - | - | |
Quick Ratio | 1.02 | 0.71 | 2.83 | 12.90 | 0.01 | 0.04 | |
Current Ratio | 1.18 | 0.75 | 2.89 | 13.45 | 0.09 | 0.06 | |
Return on Equity (ROE) | -1007.83% | -507.97% | -144.42% | -136.23% | - | - | |
Return on Assets (ROA) | -101.02% | -101.38% | -76.84% | -56.01% | -320.54% | -525.40% | |
Return on Capital (ROIC) | -148.29% | -159.52% | -88.13% | -83.15% | - | - | |
Earnings Yield | -96.90% | -88.24% | -105.61% | -14.21% | - | - | |
FCF Yield | -82.35% | -55.35% | -57.52% | -9.37% | - | - | |
Buyback Yield / Dilution | -14.76% | -15.44% | -94.44% | -31.81% | -0.03% | - | |
Total Shareholder Return | -14.76% | -15.44% | -94.44% | -31.81% | -0.03% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.